HCW Biologics Inc is trading at $1.36 (+12.24%) in after-hours trading as the stock stages a sharp technical recovery from recent selling pressure.
- The price action follows a multi-day decline triggered by investor concerns regarding a recent private placement and potential share dilution.
- No new company-specific announcements or material catalysts were identified, suggesting the move is a technical bounce amid volatile small-cap market conditions.